BAMCO Inc’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BAMCO Inc’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-675,000	Closed	-$8.42M	–	379
2019 Q1	$8.42M	Buy	675,000 +290,000	+75%	+$3.88M	0.04%	216
2018 Q4	$4.36M	Hold	385,000	–	–	0.02%	246
2018 Q3	$7.2M	Buy	385,000 +158,700	+70%	+$3.65M	0.03%	224
2018 Q2	$5.85M	Buy	226,300 +50,000	+28%	+$1.3M	0.03%	225
2018 Q1	$3.95M	Sell	176,300 -50,000	-22%	-$1.22M	0.02%	245
2017 Q4	$5.67M	Buy	226,300 +16,800	+8%	+$411K	0.03%	231
2017 Q3	$5.07M	Hold	209,500	–	–	0.02%	225
2017 Q2	$4.24M	Buy	209,500 +104,100	+99%	+$2.17M	0.02%	235
2017 Q1	$2.84M	Buy	105,400 +31,400	+42%	+$641K	0.02%	241
2016 Q4	$1.41M	Buy	74,000 +36,000	+95%	+$688K	0.01%	265
2016 Q3	$743K	Buy	38,000 +11,000	+41%	+$186K	﹤0.01%	284
2016 Q2	$404K	Buy	+27,000	New	+$339K	﹤0.01%	283

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BAMCO Inc's FLXN Position: Q2 2019 in Review

BAMCO Inc sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 675,000 shares — an estimated $8.42M sold.

BAMCO Inc first reported a position in FLXN in Q2 2016 and held it in 12 quarters. The position peaked at $8.42M in Q1 2019. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

BAMCO Inc reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
BAMCO Inc sold 675,000 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $8.42M.
BAMCO Inc first reported a position in Flexion Therapeutics, Inc. in Q2 2016 and held it in 12 quarters.
BAMCO Inc's Flexion Therapeutics, Inc. position peaked at $8.42M in Q1 2019.
129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on BAMCO Inc's 13F filing for Q2 2019, filed 15 Aug 2019.